Biogen Idec United Kingdom

Last updated: 12.03.2014

biogen-logoCompany Description

Biogen Idec creates new standards of care in therapeutic areas with high unmet medical needs. Founded in 1978, Biogen Idec is a global leader in the discovery, development, manufacturing and commercialization of innovative therapies. Patients in more than 90 countries benefit from Biogen Idec’s significant products that address diseases such as multiple sclerosis (MS), lymphoma and rheumatoid arthritis. In 2008, Biogen Idec’s total revenues grew 29 percent over 2007 to $4.1 billion. Biogen Idec is headquartered in Cambridge, Massachusetts, with international headquarters in Zug, Switzerland. They have additional offices in the US, Canada, Australia, Japan and throughout Europe. Biogen Idec has a direct commercial presence in 29 markets, a network of distribution partners in more than 70 additional markets and operations in several new markets, including Central/Eastern Europe, Brazil, China and India.

Products and Services

Biogen Idec’s products and development strategies cover a wide field of key medical issues. With regard to different therapeutic options, Biogen Idec has its focus on the areas of neurology and inflammatory diseases.

Contact Info

Biogen Idec Ltd
Innovation House
70 Norden Road
Maidenhead, Berkshire SL6 4AY
United Kingdom

Phone: 44 1628 501000
Fax: 44 1628 501010


We use cookies to ensure that we give you the best experience on our site. For more info click here